fig1
![Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma](https://image.oaes.cc/48c8c94c-9217-46fe-b8f0-bbf99cd0e0b2/2921.fig.1.jpg)
Figure 1. Distribution of marker-positive patients. Distribution of the patients positive for aspartate aminotransferase (AST), alpha-fetoprotein (AFP), and des-gamma-carboxy prothrombin (DCP) in patients with nonB-nonC hepatocellular carcinoma (NBNC-HCC). The majority (97.6%) of patients with NBNC-HCC showed elevations in AST, AFP and/or DCP over the selected cut-offs (A); distribution of the three markers in patients with diabetes mellitus (B). One-fourth (27.4%) of the patients showed elevations in AST, AFP, and/or DCP over the selected cut-offs